592 Updated recurrence free survival for neoadjuvant bintrafusp alfa (BA) for HPV unrelated HNSCC and results from BA plus a multitargeted recombinant adenovirus 5 vaccine for HPV unrelated HNSCC

• Jeffrey Schlom,
• James L Gulley,
• Jennifer Marte,
• Elizabeth Lamping,
• Lisa Cordes,
• Seth M Steinberg,
• Charalampos Floudas,
• Jason M Redman,
• Clint Allen

Affiliations

Jeffrey Schlom

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

James L Gulley

4 National Cancer Institute, Bethesda, Maryland, USA

Jennifer Marte

1Center for Immuno-Oncology, NCI, Bethesda, MD, USA

Elizabeth Lamping

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Lisa Cordes

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Seth M Steinberg

Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Charalampos Floudas

1Center for Immuno-Oncology, NCI, Bethesda, MD, USA

Jason M Redman

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Clint Allen

Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA